S
Silvano Gallus
Researcher at Mario Negri Institute for Pharmacological Research
Publications - 420
Citations - 48395
Silvano Gallus is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 68, co-authored 352 publications receiving 27505 citations. Previous affiliations of Silvano Gallus include Centro Studi GISED & Thomas Jefferson University.
Papers
More filters
Journal ArticleDOI
Tobacco control: economic aspects of smoking.
Silvano Gallus,Carlo La Vecchia +1 more
Journal ArticleDOI
Meat consumption is not tobacco smoking.
Silvano Gallus,Cristina Bosetti +1 more
TL;DR: It is crucial to underline that the risk of cancer in relation to meat is—both at an individual and at a population level—extremely limited as compared to that of (cigarette) smoking.
Journal ArticleDOI
Aldehyde Dehydrogenase 2 Polymorphism Is a Predictor of Smoking Cessation
Hiroyuki Masaoka,Silvano Gallus,Hidemi Ito,Miki Watanabe,Akira Yokomizo,Masatoshi Eto,Keitaro Matsuo +6 more
TL;DR: It is shown that subjects with ALDH2 Lys/Lys genotype in a functional polymorphism, rs671, are more likely to quit smoking than those with AlDH2 Glu allele in a Japanese population, suggesting that AL DH2 polymorphism may be useful for promoting smoking cessation in those specific populations as East Asian ones with frequent ALDH 2 Lys allele carriers.
Journal ArticleDOI
Variabilidad en el consumo de cigarrillos según la fuente de información en España (1993-2009)
Jose M. Martínez-Sánchez,Jose M. Martínez-Sánchez,Marcela Fu,Marcela Fu,Silvano Gallus,Xisca Sureda,Xisca Sureda,Carlo La Vecchia,Carlo La Vecchia,Esteve Fernández,Esteve Fernández +10 more
TL;DR: In this article, analizar the variabilidad in the number of cigarrillos fumados per persona and dia in Espana segun la fuente de información (encuestas de salud and datos de ventas) is presented.
Journal ArticleDOI
Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury.
Francesca Pischiutta,Enrico Caruso,Enrico Caruso,Alessandra Lugo,Helena Cavaleiro,Nino Stocchetti,Nino Stocchetti,Giuseppe Citerio,António J. Salgado,Silvano Gallus,Elisa R. Zanier +10 more
TL;DR: In this article, the authors made a systematic review and meta-analysis to assess the quality of evidence for mesenchymal stromal cells (MSCs) treatment in TBI rodent models and determine the effect size of MSCs on sensorimotor function, cognitive function, and anatomical damage.